Join
Live feed
·
INSIDERFilingvia Quantisnow
First Wave BioPharma Inc. logo

Khosla Chaitan Phd was granted 440 shares (SEC Form 4)

ByQuantisnow·Wall Street's wire, on your screen.
FWBI· First Wave BioPharma Inc.
Health Care
Original source

This insight was delivered by - Wall Street's wire, on your screen. Quantisnow is a real-time market data and news platform for retail investors, aggregating SEC filings, FDA approvals, analyst ratings, insider trading, and press releases into a single customizable feed. Track FWBI (First Wave BioPharma Inc.) and more on Quantisnow.

Khosla Chaitan Phd was granted 440 shares (SEC Form 4) | Quantisnow